| From : | Mandar Mhatre/INT BIZ/PBP <Mandar.Mhatre@Cipla.com> |
| To : | Maia Nikoleishvili <mnikoleishvili@moh.gov.ge> |
| Subject : | RE: Request from MoH Georgia regarding procuring Remdesivir from Cipla |
| Cc : | Tamar Gabunia <tgabunia@moh.gov.ge>; a.dzuliashvili@mfa.gov.ge; Anchal Sultania/FIN/PBP <Anchal.Sultania@Cipla.com> |
| Received On : | 15.10.2020 07:55 |
Dear Maia,
We await your feedback on the CDA. Once we get the sign copy, we can send you our commercial offer.
Look forward.
Thanks,
Mandar
From: Mandar Mhatre/INT BIZ/PBP
Sent: 13 October 2020 20:07
To: Maia Nikoleishvili
Cc: Tamar Gabunia
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Cipla
Dear Maia,
Many thanks for your email. We will come back to you on our commercial offer along with the supply timelines. Meanwhile, I would request you to please review
the attached CDA and if ok, both sides can sign it before we send you the offer.
Look forward.
Thanks & Regards,
Mandar
From: Maia Nikoleishvili [mailto:mnikoleishvili@moh.gov.ge]
Sent: 13 October 2020 19:49
To: Mandar Mhatre/INT BIZ/PBP <Mandar.Mhatre@Cipla.com>
Cc: Tamar Gabunia <tgabunia@moh.gov.ge>;
a.dzuliashvili@mfa.gov.ge
Subject: Request from MoH Georgia regarding procuring Remdesivir from Cipla
This message is from an EXTERNAL SENDER - be CAUTIOUS, particularly with links and attachments.
Dear Mr. Mandar,
I would like to kindly address you from the Ministry of Internally Displaced Persons from the Occupied Territories,
Labour, Health and Social Affairs of Georgia regarding procuring generic form of Remdesivir manufactured by Cipla under a license from Gilead Science Inc.
Considering current epidemiological situation, we are committed to use all existing opportunities, including engagement
in the study of Remdesivir for the treatment of the patients with severe acute respiratory syndrome of COVID-19 in order to avoid fatal outcomes in the infected patients as far as possible.
Therefore, we urgently need to procurer Remdesivir (3000 vial) initially sufficient for 500 eligible patients and
kindly request you to provide us with the product price as well as terms and conditions of delivery as early as possible.
We rely on your support and do hope that our cooperation will be fruitful and successful.
Looking forward to receiving your feedback as soon as possible.
Sincerely yours,
Maia Nikoleishvili MPA
Head of International Relations and Protocol Division
Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs of Georgia
Address: 144 Tsereteli ave., 0159 Tbilisi, Georgia
Tel.: +995 32 2510034 (0803)
Cell phone: +995 577272713
E-mail:
mnikoleishvili@moh.gov.ge